The mission of Quotient Pharmaceuticals Manufacturing and its leadership is to develop, commercially manufacture, and market new proprietary technologies in the natural human antibody field.
Quotient Pharmaceuticals Manufacturing is an innovative, biopharmaceutical company that has the potential to revolutionize the standard of care for the treatment of several of the world’s most pressing healthcare issues.
Quotient specializes in development of polyclonal human antibodies sourced from the plasma of special donors who have been stimulated to produce high concentrations of potent antibodies.
Quotient's technology platform is built on a history of scientific and commercial success, with proven reliable use of human antibodies as safe treatment
We believe Quotient’s immunology platform can address severe unmet medical needs in some of the largest biopharmaceutical markets. We are organizing our initial product line around three primary areas below and a link to understand the Plasma Protein and Immune Globulin market.
Quotient specializes in development of polyclonal human antibodies sourced from the plasma of special donors who have been stimulated to produce high concentrations of potent antibodies.
Quotient's technology platform is built on a history of scientific and commercial success, with proven reliable use of human antibodies as safe treatment
We believe Quotient’s immunology platform can address severe unmet medical needs in some of the largest biopharmaceutical markets. We are organizing our initial product line around three primary areas below and a link to understand the Plasma Protein and Immune Globulin market.
Allergy and
|
Inflammatory Disease and Autoimmune
|
Neuropathic Pain and
|
Plasma Proteins and Immune Globulin
|
Click on images to learn more